普洛药业：子公司获头孢地尼干混悬剂药品注册证书

Core Viewpoint - Pro Pharmaceutical Co., Ltd. has received a drug registration certificate for Cefdinir Dry Suspension from the National Medical Products Administration, indicating a significant advancement in its product offerings in the pediatric antibiotic market [1] Group 1: Company Developments - Pro Pharmaceutical's wholly-owned subsidiary, Zhejiang Proluo Jutai Pharmaceutical Co., Ltd., is the entity that received the registration certificate [1] - The newly approved Cefdinir Dry Suspension is classified as a third-generation oral cephalosporin antibiotic [1] Group 2: Product Information - Cefdinir Dry Suspension is indicated for the treatment of mild to moderate infections caused by sensitive strains of specified microorganisms in pediatric patients [1]